Nevertheless, AMPK is the only member of the ARK family known to inhibit most biosynthetic pathways (i.e. cell growth) as well as progress through the cell cycle (i.e. cell division) [81], and therefore still seemed the best candidate to account for the tumour suppressor effects of LKB1. The gene discussed is PRKAA2; the disease is neoplasm.